Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM193B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CNN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIR-FIGF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ME2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGSF22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CDK6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF664-FAM101A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAPEPLD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNM1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP6V0A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZXDB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GOSR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMOD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPRIN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFRSF17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on